We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

69 hedge funds and large institutions have $64.9M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 25

3% less funds holding

Funds holding: 71 → 69 (-2)

9% less capital invested

Capital invested by funds: $71.3M → $64.9M (-$6.33M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
69
Holders Change
-2
Holders Change %
-2.82%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
24
Reduced
25
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
+$885K
2
Millennium Management
Millennium Management
New York
+$391K
3
MC
Menta Capital
California
+$286K
4
Northern Trust
Northern Trust
Illinois
+$210K
5
PPA
Parametric Portfolio Associates
Washington
+$177K

Top Sellers

Rank Fund Capital Flow
1
TC
TFS Capital
Pennsylvania
-$1.17M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
-$671K
3
BIT
BlackRock Institutional Trust
California
-$471K
4
AG
Algert Global
California
-$358K
5
HVC
Healthcare Value Capital
New Jersey
-$299K
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$11.7M +$1.33K +200 +0%
GIM
2
Granahan Investment Management
Massachusetts
$9.03M +$885K +133,186 +11%
BFA
3
BlackRock Fund Advisors
California
$6.21M +$9.55K +1,438 +0.2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$5.84M -$37.5K -5,649 -0.6%
PI
5
Putnam Investments
Massachusetts
$5.03M -$22.2K -3,338 -0.4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$4.08M +$71.6K +10,784 +2%
Millennium Management
7
Millennium Management
New York
$2.33M +$391K +58,860 +20%
USAA
8
United Services Automobile Association
Texas
$1.86M – – –
Northern Trust
9
Northern Trust
Illinois
$1.45M +$210K +31,598 +17%
State Street
10
State Street
Massachusetts
$1.43M +$16.5K +2,489 +1%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$1.31M -$281K -42,304 -17%
PAMU
12
Pictet Asset Management (UK)
United Kingdom
$1.21M -$671K -101,100 -35%
BIT
13
BlackRock Institutional Trust
California
$1.05M -$471K -70,940 -30%
NFA
14
Nationwide Fund Advisors
Ohio
$1.03M +$2.2K +331 +0.2%
CCM
15
Cadence Capital Management
Massachusetts
$992K -$28K -4,210 -3%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$966K -$93.8K -14,125 -9%
BCM
17
Bridgeway Capital Management
Texas
$848K – – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
$672K +$7.55K +1,137 +1%
CCMH
19
Cornerstone Capital Management Holdings
New York
$653K +$99.6K +15,000 +18%
MC
20
Menta Capital
California
$627K +$286K +43,100 +81%
SO
21
STRS Ohio
Ohio
$597K +$19.3K +2,900 +3%
TCIM
22
TIAA CREF Investment Management
New York
$394K -$21.6K -3,247 -5%
BIM
23
BlackRock Investment Management
Delaware
$337K +$13.6K +2,041 +4%
HVC
24
Healthcare Value Capital
New Jersey
$336K -$299K -45,000 -47%
OAM
25
Oberweis Asset Management
Illinois
$336K -$193K -29,000 -36%
1
2 3

SCMP Hedge Fund Activity: Q3 2014 in Review

69 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q3 2014, worth a combined $64.9M — down 8.9% from $71.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SCMP and 4 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 24 added.

The largest buyer was Granahan Investment Management, adding an estimated $885K. The largest seller was TFS Capital, exiting entirely with an estimated $1.17M sold.

  • 69 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q3 2014, down from 71 in Q2 2014.
  • Funds reported $64.9M of Sucampo Pharmaceuticals, Inc. stock for Q3 2014, down 8.9% quarter-over-quarter.
  • 4 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q3 2014 and 6 closed out, a net change of -2 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q3 2014 was Granahan Investment Management, an estimated $885K added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q3 2014 was TFS Capital, an estimated $1.17M sold.

Based on aggregated 13F filings for Q3 2014.